Preclinical Development of Drugs with Special Emphasis on Biologicals

Instructor: Michel Awwad
Product ID: 706465
Training Level: Advanced
  • 8
  • July 2020
  • 10:00 AM PDT | 01:00 PM EDT
    Duration: 60 Min
Preclinical development is a critical stage of drug development that determines as well as measures the “therapeutic” doses needed and the ability to achieve these doses. Moreover, preclinical studies assess the safety of the drug at these doses.

Live Online Training
July 08, Wednesday 10:00 AM PDT | 01:00 PM EDT | Duration: 60 Min

One Dial-in One Attendee
Group-Max. 10 Attendees/Location
(For Multiple Locations Contact Customer Care)
Super Deal - Get CD/USB Drive Free!

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days after completion of Live training

Combo Offers

Live + Recorded Version


Live + Training CD/USB


Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

Why Should You Attend:

To successfully develop a therapeutic drug one needs to understand, in addition to the choice of target and indication and the segment of patients to treat. One needs to understand what the drug does to the patient (toxicological) and what the patient would do to the drug (metabolism and clearance). Preclinical development, utilizing relevant animal models, attempts to clear the later points.

In this webinar, we will discuss strategies needed to successfully develop a drug followed by a brief discussion of the stages of drug development and the functional groups associated with each of the three stages. We will demonstrate that preclinical development is a stage that spans the entire drug development phase.

Preclinical development activities start at discovery to help candidate selection, determining the safety of the drug and determining the therapeutic doses as well as calculates the first in human dose. Preclinical and nonclinical activities do not end when the drug enters clinical studies but continues until marketing or even after that.

Areas Covered in the Webinar:

  • Strategy of drug development
  • Stages of drug development and the functional groups associated with each stage
  • Activities associated with preclinical development include
    • Toxicological studies
      • These comprise of many different studies, such as general toxicity, reproductive toxicity, carcinogenicity and others
    • Pharmacokinetic and pharmacodynamic activity
      • Determine metabolism and excretion of the drug
      • Determine therapeutic dose
      • Determine first in human dose
  • Pre-IND Meeting with regulators
  • Submitting an IND application

Who Will Benefit:

  • Preclinical development scientists such as Bioanalytical scientist and toxicologists
  • Research and development scientists developing drugs
  • Manufacturing scientists

From industries including biotech and pharmaceuticals

Free Materials:

  • Reference documents
  • Rule documents or guidance
  • Checklist
  • SOP template
  • Easy fill in forms
  • Articles
Instructor Profile:
Michel Awwad

Michel Awwad
Preclinical Development, Indivisual

Scientist with more than 20 years of experience in small biotechnology and large pharmaceutical companies. Developed protein-based (peptides, mAb, ADC, bispecific antibodies), small molecules and liposomal products. Carried these products from inception through preclinical development into early clinical development. Developed products for the treatment and diagnosis of cancer, for the treatment of immunological diseases, including those that can facilitate transplantation of solid organs, and for neurological dieses (Alzheimer’s). Directed the safety as well as bioanalytical studies (PK and Immunogenicity) of many of the products in the preclinical setting. wrote Preclinical sections of regulatory submissions.

Follow us :
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)
The Use of Drug Master Files & Quality Agreements

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed